Funding confirmed for Cambridge Cancer Research Hospital

Prime Minister Boris Johnson has formally announced that the government will fund the new Cambridge Cancer Research Hospital at Addenbrooke’s. This news follows years of meticulous planning and hard work.

Professor Richard Gilbertson, Director of the CRUK Cambridge Centre at the University of Cambridge said: “I would like to take the opportunity to thank all those involved in the incredible partnership between the CRUK Cambridge Centre, Cambridge University Hospitals NHS Foundation Trust and the University that has made this possible.

“Today’s announcement gives a true ‘green light’ to the building of this much needed facility for our patients.”

The Cambridge Cancer Research Hospital is included as part of a funding package worth £3.7 billion to build 40 new hospitals over the next 10 years, within the government’s Health Infrastructure Plan (HIP). We are awaiting further details about the funding but it has accelerated an already ambitious Outline Business Case that will lead ultimately to the building of the new hospital by 2025.

The new Cambridge Cancer Research Hospital will connect clinical expertise from Addenbrooke’s with world-class science across the University of Cambridge and our industrial partners – literally bringing bench to bedside – enabling patients to benefit from the latest innovations in early cancer detection, precision cancer medicine and treatment. Uniting brilliant minds from across the world, outstanding healthcare and patients, the hospital will provide an unparalleled opportunity to detect cancer earlier and treat it more precisely – improving and saving the lives of patients.

Roland Sinker, CEO at Cambridge University Hospitals, said: “We welcome the Prime Minister’s funding announcement for the Cambridge Cancer Research Hospital. Cambridge Cancer will rewrite the story of cancer; it will bring together world-class clinicians from Addenbrooke’s Hospital with cutting-edge Cambridge research and industry, enabling early detection of cancer and delivering bespoke, precision treatments that will radically improve patient outcomes.

“This national facility will bring hope for cancer patients regionally, nationally and internationally, and we look forward to progressing this project at a rapid pace.”